Although the genetic culprits are many and the biology complex, Yale geneticist Matthew State and neurobiologist Nenad Sestan, argue in the 14 September issue of the journal Science that researchers are now well positioned to unravel the pathology underlying autism spectrum disorders and to identify new and more personalized approaches to its treatment.
